<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">ASN Neuro</journal-id>
<journal-id journal-id-type="iso-abbrev">ASN Neuro</journal-id>
<journal-id journal-id-type="publisher-id">ASN</journal-id>
<journal-id journal-id-type="hwp">spasn</journal-id>
<journal-title-group>
<journal-title>ASN NEURO</journal-title>
</journal-title-group>
<issn pub-type="epub">1759-0914</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32443939</article-id>
<article-id pub-id-type="pmc">7249604</article-id>
<article-id pub-id-type="doi">10.1177/1759091420925335</article-id>
<article-id pub-id-type="publisher-id">10.1177_1759091420925335</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Shedding Light on the Dark Side of the Microglia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>St-Pierre</surname>
<given-names>Marie-Kim</given-names>
</name>
<xref ref-type="aff" rid="aff1-1759091420925335">1</xref>
<xref ref-type="corresp" rid="corresp1-1759091420925335"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Šimončičová</surname>
<given-names>Eva</given-names>
</name>
<xref ref-type="aff" rid="aff1-1759091420925335">1</xref>
<xref ref-type="aff" rid="aff2-1759091420925335">2</xref>
<xref ref-type="aff" rid="aff3-1759091420925335">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bögi</surname>
<given-names>Eszter</given-names>
</name>
<xref ref-type="aff" rid="aff2-1759091420925335">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-2863-9626</contrib-id>
<name>
<surname>Tremblay</surname>
<given-names>Marie-Ève</given-names>
</name>
<xref ref-type="aff" rid="aff1-1759091420925335">1</xref>
</contrib>
<aff id="aff1-1759091420925335">
<label>1</label>Axe Neurosciences, Centre de Recherche du CHU de
Québec-Université Laval</aff>
<aff id="aff2-1759091420925335">
<label>2</label>Department of Pharmacology, Jessenius Faculty of Medicine,
Comenius University, Martin, Slovak Republic</aff>
<aff id="aff3-1759091420925335">
<label>3</label>Institute of Experimental Pharmacology and Toxicology, Centre of
Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak
Republic</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1759091420925335">Marie-Ève Tremblay, Division of Medical
Sciences, University of Victoria, Victoria, BC V8W 2Y2, Canada. Email:
<email>evetremblay@uvic.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<season>Jan-Dec</season>
<year>2020</year>
</pub-date>
<volume>12</volume>
<elocation-id>1759091420925335</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>4</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
<license license-type="creative-commons" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">
<license-p>Creative Commons Non Commercial CC BY-NC: This article is distributed
under the terms of the Creative Commons Attribution-NonCommercial 4.0
License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which
permits non-commercial use, reproduction and distribution of the work
without further permission provided the original work is attributed as
specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Microglia, the resident immune cells of the central nervous system, are not a
homogeneous population; their morphology, molecular profile, and even their
ultrastructure greatly vary from one cell to another. Recent advances in the
field of neuroimmunology have helped to demystify the enigma that currently
surrounds microglial heterogeneity. Indeed, numerous microglial subtypes have
been discovered such as the disease-associated microglia, neurodegenerative
phenotype, and Cd11c-positive developmental population. Another subtype is the
dark microglia (DM), a population defined by its ultrastructural changes
associated with cellular stress. Since their first characterization using
transmission electron microscopy, they have been identified in numerous disease
conditions, from mouse models of Alzheimer’s disease, schizophrenia, fractalkine
signaling deficiency to chronic stress, just to name a few. A recent study also
identified the presence of cells with a similar ultrastructure to the DM in
<italic>postmortem</italic> brain samples from schizophrenic patients,
underlining the importance of understanding the function of these cells. In this
minireview, we aim to summarize the current knowledge on the DM, from their
initial ultrastructural characterization to their documentation in various
pathological contexts across multiple species. We will also highlight the
current limitations surrounding the study of these cells and the future that
awaits the DM.</p>
</abstract>
<kwd-group>
<kwd>dark microglia</kwd>
<kwd>heterogeneity</kwd>
<kwd>nonhomeostatic conditions</kwd>
<kwd>postnatal development</kwd>
<kwd>electron microscopy, mouse models, human brain samples</kwd>
</kwd-group>
<funding-group>
<award-group id="award1-1759091420925335">
<funding-source id="funding1-1759091420925335">
<institution-wrap>
<institution>Canada Research Chairs</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001804</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-December 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>typesetter</meta-name>
<meta-value>ts2</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>Since the first description of microglia by Pío del Río Hortega, major advances in
understanding their origin, morphological, functional, and genetic aspects were
uncovered by pioneering research (<xref ref-type="bibr" rid="bibr47-1759091420925335">Sierra et al., 2019</xref>). Stemming from the
predominant focus of the past two decades on the role of microglia in pathological
conditions, a passionate debate began to revolve around their function in the
homeostatic maintenance of the healthy brain and their phenotypic diversity (<xref ref-type="bibr" rid="bibr41-1759091420925335">Salter and Stevens, 2017</xref>;
<xref ref-type="bibr" rid="bibr53-1759091420925335">Stratoulias et al.,
2019</xref>).</p>
<p>In spite of comprising approximately only 10% of the total central nervous system
(CNS) cell population, microglia are found to be extensively, albeit unevenly,
distributed throughout the white and gray matter (<xref ref-type="bibr" rid="bibr29-1759091420925335">Lawson et al., 1990</xref>) and are essential for
the regulation of complex developmental, homeostatic, and pathological processes
(<xref ref-type="bibr" rid="bibr41-1759091420925335">Salter and Stevens,
2017</xref>). Aside from acting as the CNS innate immune defense system in
response to environmental stressors, microglia are known to regulate neuronal
development and synaptic plasticity most notably during learning and the adaptation
to the environment (<xref ref-type="bibr" rid="bibr55-1759091420925335">Tremblay
et al., 2010</xref>; <xref ref-type="bibr" rid="bibr44-1759091420925335">Schafer
et al., 2012</xref>; <xref ref-type="bibr" rid="bibr38-1759091420925335">Parkhurst et al., 2013</xref>). Not only are they able to facilitate genesis
and maturation of new synapses (<xref ref-type="bibr" rid="bibr38-1759091420925335">Parkhurst et al., 2013</xref>), considerable data have highlighted several
pathways by which microglia mediate synaptic pruning, that is, the elimination of
exuberant or dysfunctional synapses. Microglia are able to affect synaptic
plasticity through phagocytosis of whole synaptic connections (<xref ref-type="bibr" rid="bibr55-1759091420925335">Tremblay et al., 2010</xref>; <xref ref-type="bibr" rid="bibr37-1759091420925335">Paolicelli et al., 2011</xref>),
synaptic “nibbling” (trogocytosis; <xref ref-type="bibr" rid="bibr58-1759091420925335">Weinhard et al., 2018</xref>), or physical
separation of pre- and postsynaptic elements with the help of their dynamic
processes known as synaptic stripping (<xref ref-type="bibr" rid="bibr35-1759091420925335">Moran and Graeber, 2004</xref>).</p>
<p>Efficient remodeling and refinement of synaptic connections are imperative for
adequate brain wiring (<xref ref-type="bibr" rid="bibr44-1759091420925335">Schafer
et al., 2012</xref>; <xref ref-type="bibr" rid="bibr24-1759091420925335">Kettenmann et al., 2013</xref>). Abnormal microglial activity resulting from
aging or pathological insults was associated with connectivity issues underlying
cognitive impairments and behavioral deviations across models of numerous
neurodevelopmental disorders, such as schizophrenia (<xref ref-type="bibr" rid="bibr46-1759091420925335">Sellgren et al., 2019</xref>) and autistic
spectrum disorders (<xref ref-type="bibr" rid="bibr62-1759091420925335">Zhan et al.,
2014</xref>; <xref ref-type="bibr" rid="bibr25-1759091420925335">Kleinhans
et al., 2016</xref>), as well as neurodegenerative diseases such as Alzheimer’s
disease (AD; <xref ref-type="bibr" rid="bibr17-1759091420925335">Hong et al.,
2016</xref>) and Parkinson’s disease (PD; <xref ref-type="bibr" rid="bibr30-1759091420925335">Lecours et al., 2018</xref>).</p>
<p>Expanding literature strongly supports the notion that microglia comprise a
heterogenous population with region- and state-specific differences in distribution,
morphology, molecular signature, and function across the lifespan (<xref ref-type="bibr" rid="bibr15-1759091420925335">Hammond et al., 2019</xref>; <xref ref-type="bibr" rid="bibr53-1759091420925335">Stratoulias et al., 2019</xref>).
Moreover, in response to specific stimuli and local microenvironment cues, multiple
adaptive morphological phenotypes have been described— from steady-state ramified
microglia to amoeboid, hypertrophic, rod-like, and dystrophic/senescent microglia
(<xref ref-type="bibr" rid="bibr42-1759091420925335">Savage et al.,
2019a</xref>). The concept of microglial heterogeneity has grown over the past
years, and several distinctive subpopulations/phenotypes were brought to light by
means of state-of-the-art imaging techniques, genetic approaches, or transcriptomic
single-cell/bulk RNA analyses. A transient surge of a CD11c+ microglial
subpopulation was detected in early postnatal development, supporting neurogenesis
and myelination primarily in white matter regions (<xref ref-type="bibr" rid="bibr60-1759091420925335">Wlodarczyk et al., 2017</xref>). Comparable on
spatiotemporal and functional levels, the proliferative-region-associated microglia
subset was described as amoeboid-like shaped and possessing high phagocytic and
metabolic activity (<xref ref-type="bibr" rid="bibr13-1759091420925335">Hagemeyer
et al., 2017</xref>; <xref ref-type="bibr" rid="bibr31-1759091420925335">Li
et al., 2019</xref>; <xref ref-type="bibr" rid="bibr51-1759091420925335">Staszewski and Hagemeyer, 2019</xref>). It was also shown transcriptionally
that proliferative-region-associated microglia significantly overlap with the
disease-associated microglia (DAM) subpopulation (<xref ref-type="bibr" rid="bibr23-1759091420925335">Keren-Shaul et al., 2017</xref>), whose putative
neuroprotective function has been suggested in the early stages of AD (<xref ref-type="bibr" rid="bibr7-1759091420925335">Deczkowska et al., 2018</xref>).
Microglia are no longer considered a homogenous population, and a greater
understanding of the mechanisms behind the genesis of their subpopulations and
susceptibility toward different phenotypes could hold the key to improve the
treatment of neurological disorders.</p>
<sec id="sec2-1759091420925335">
<title>Discovering the Dark Microglia</title>
<p>Microglial heterogeneity is currently experiencing an intellectual boom as novel
microglial subpopulations/phenotypes (subtypes) are emerging. One of these are the
dark microglia (DM), whose identification, using high-spatial resolution
transmission electron microscopy, was based on their unique dark appearance and
distinctive ultrastructural features (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). Although DM research
has markedly progressed since their initial discovery (see <xref ref-type="table" rid="table1-1759091420925335">Table 1</xref> for overview), a veil of mystery
still covers several key features of these cells, for example, cell-specific
markers, origin, and their functionality across disease contexts. For this reason,
ultrastructural analysis is presently the most appropriate tool to characterize and
study the DM.</p>
<table-wrap id="table1-1759091420925335" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Summary of the Studies Describing Dark Microglial Cells.</p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1759091420925335-table1"></graphic>
<table frame="hsides" rules="groups">
<thead valign="top">
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1">Species</th>
<th colspan="1" rowspan="1">Model</th>
<th colspan="1" rowspan="1">Age at sacrifice</th>
<th colspan="1" rowspan="1">Region</th>
<th colspan="1" rowspan="1">Ultrastructural description</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="1" rowspan="4">(<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>)</td>
<td colspan="1" rowspan="4">Mouse</td>
<td colspan="1" rowspan="1">C57BL/6</td>
<td colspan="1" rowspan="1">14 months</td>
<td colspan="1" rowspan="4">
<p>Hippocampal CA1</p>
<p>Subgranular layer of the cerebral cortexBasolateral
amygdalaMedian eminence of the hypothalamus</p>
</td>
<td colspan="1" rowspan="4">Electron-dense cyto- and nucleoplasm ER and Golgi
dilation Altered mitochondria Loss of heterochromatin
pattern Processes with acute angles Interaction with
synapses Near vasculature elements Highly phagocytic</td>
</tr>
<tr>
<td colspan="1" rowspan="1">APP<sup>Swe</sup>-PS1ΔE9</td>
<td colspan="1" rowspan="1">6, 14, and 21 months</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CX3CR1 KO (with/without stress)</td>
<td colspan="1" rowspan="1">16–20 weeks</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Social defeat stress</td>
<td colspan="1" rowspan="1">8–9 weeks</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="bibr20-1759091420925335">Hui et al.,
2018</xref>)</td>
<td colspan="1" rowspan="1">Mouse</td>
<td colspan="1" rowspan="1">C57BL/6, Poly I:C injection at E9.5</td>
<td colspan="1" rowspan="1">P80-P90</td>
<td colspan="1" rowspan="1">Dentate gyrus polymorphic layer</td>
<td colspan="1" rowspan="1">Dark microglia defined by Bisht et al.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="bibr10-1759091420925335">Elgayar
et al., 2018</xref>)</td>
<td colspan="1" rowspan="1">Rat</td>
<td colspan="1" rowspan="1">Albino, rotenone injection</td>
<td colspan="1" rowspan="1">Adult</td>
<td colspan="1" rowspan="1">
<italic>Substantia nigra</italic>
</td>
<td colspan="1" rowspan="1">
<p>Dark microglia defined by Bisht et al.</p>
<p>Associated with blood capillaries</p>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="bibr56-1759091420925335">Uranova
et al., 2018</xref>)</td>
<td colspan="1" rowspan="1">Human</td>
<td colspan="1" rowspan="1">
<p>Schizophrenia patients</p>
<p>(<italic>n</italic> = 21)</p>
</td>
<td colspan="1" rowspan="1">56.4 ± 17.2 years old</td>
<td colspan="1" rowspan="1">White matter near the Layer VI of prefrontal cortex</td>
<td colspan="1" rowspan="1">Described as dystrophic microglia (dark and electron-dense
nucleus, cytoplasm with vacuoles)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="bibr9-1759091420925335">El Hajj
et al., 2019</xref>)</td>
<td colspan="1" rowspan="1">Mouse</td>
<td colspan="1" rowspan="1">APP<sup>Swe</sup>-PS1ΔE9</td>
<td colspan="1" rowspan="1">14 months</td>
<td colspan="1" rowspan="1">Hippocampal CA1 <italic>strata radiatum</italic> and
<italic>lacunosum-moleculare</italic></td>
<td colspan="1" rowspan="1">
<p>Dark microglia defined by Bisht et al., (associated with
plaques and TREM2+)</p>
<p>Intermediate stages of dark microglia (typical microglial
heterochromatin pattern, darker cytoplasm, ER dilation)</p>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="bibr22-1759091420925335">Kavetsky
et al., 2019</xref>)</td>
<td colspan="1" rowspan="1">Mouse</td>
<td colspan="1" rowspan="1">C57BL/6-<italic>Npc1<sup>nmf164</sup></italic>, Western
diet</td>
<td colspan="1" rowspan="1">8 weeks</td>
<td colspan="1" rowspan="1">Molecular layer of the cerebellum</td>
<td colspan="1" rowspan="1">Dark activated microglial processes interacting with
synapses</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="bibr3-1759091420925335">Calì et al.,
2019</xref>)</td>
<td colspan="1" rowspan="1">Rat</td>
<td colspan="1" rowspan="1">Unknown</td>
<td colspan="1" rowspan="1">P14</td>
<td colspan="1" rowspan="1">Layer VI of somatosensory cortex</td>
<td colspan="1" rowspan="1">Darker cytosol</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="bibr39-1759091420925335">Pedicone
et al., 2020</xref>)</td>
<td colspan="1" rowspan="1">Mouse</td>
<td colspan="1" rowspan="1">3-month-old C57BL/6, injected biweekly for 3 weeks with
K161</td>
<td colspan="1" rowspan="1">4 months</td>
<td colspan="1" rowspan="1">Cerebral cortex</td>
<td colspan="1" rowspan="1">Not determined</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="table-fn1-1759091420925335">
<p><italic>Note</italic>. ER = endoplasmic reticulum; KO = knockout;
TREM2 = triggering receptor expressed on myeloid cells 2.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>At first glance, the most obvious ultrastructural feature distinguishing DM from
typical microglia is their altered heterochromatin pattern (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). Compared with typical
microglia, whose nucleoplasm consists of a lighter, electron-lucent euchromatin,
accompanied by a dark, electron-dense heterochromatin lining the inner part of the
nuclear membrane and small dark patches randomly distributed throughout the
nucleoplasm (<xref ref-type="bibr" rid="bibr40-1759091420925335">Peters et al.,
1991</xref>), DM display a condensed and electron-dense nucleoplasm resulting in
a near loss of the classical microglial pattern (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). Previous studies have
suggested that considerable chromatin remodeling is associated with active
phenotypic changes driven by altered gene expression (<xref ref-type="bibr" rid="bibr28-1759091420925335">Lardenoije et al., 2015</xref>). This association,
however, has not yet been investigated in the DM. It was also suggested that the DM
appearance emanates from well-preserved proteins exhibiting high affinity toward
osmium tetroxide, a fixative used for the preparation of electron microscopy samples
to contrast lipids (<xref ref-type="bibr" rid="bibr1-1759091420925335">Bisht et al.,
2016a</xref>; for a more detailed explanation of electron microscopy sample
preparation for DM analyses, see <xref ref-type="bibr" rid="bibr52-1759091420925335">St-Pierre et al., 2019</xref>). Furthermore, DM display several oxidative and
metabolic stress-induced alterations including disrupted mitochondria, dilation of
the Golgi apparatus and endoplasmic reticulum, as well as cell shrinkage (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). It is
important to note that while DM show ultrastructural alterations, evidence from
electron microscopy analyses suggests that DM are not undergoing apoptosis or
necrosis considering their lack of various nuclear alterations associated with these
modes of cell death (e.g., blebbing, rounding, fragmentation; <xref ref-type="bibr" rid="bibr1-1759091420925335">Bisht et al., 2016a</xref>) (<xref ref-type="fig" rid="fig1-1759091420925335">Figure 1</xref>). However, thorough molecular
analyses would be required to confirm that these cells are not dying.</p>
<fig id="fig1-1759091420925335" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Electron micrographs of typical (A), intermediate (B) and dark microglia (C)
in the hippocampus CA1, <italic>strata radiatum </italic>and
<italic>lacunosum-moleculare</italic>, of mice given a high fat diet,
taken at a resolution of 5 nm using a scanning electron microscope. A:
Typical microglia are shown with an electron-lucent cytoplasm and a clear
heterochromatin pattern. B and C: Intermediate and dark microglia display an
electron-dense cyto- and nucleoplasm that possesses either a chromatin
pattern similar to typical microglia (intermediate microglia, B) or a
complete loss of chromatin pattern (dark microglia, C). Signs of oxidative
stress (dilation of the endoplasmic reticulum, elongated mitochondria) as
well as phagocytic inclusions are shown in B and C. Yellow
contour = nucleus, red contour = cytoplasm and nucleus,
green = mitochondrion, pink = postsynaptic element, light
purple = presynaptic element, orange = phagocytic inclusion, * = dilation of
endoplasmic reticulum, and blue = elongated mitochondrion. Scale bars = 5
µm.</p>
</caption>
<graphic xlink:href="10.1177_1759091420925335-fig1"></graphic>
</fig>
<p>DM also possess numerous thin and long processes forming acute angles in contrast to
the typical microglia that display thicker and shorter processes with more obtuse
angles (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al.,
2016b</xref>; <xref ref-type="fig" rid="fig1-1759091420925335">Figure 1</xref>).
Previous transmission electron microscopy observations have shown that DM
extensively interact with their microenvironment, making contacts with neurons,
other glial cells, and components of the neuropil (axon terminals, dendritic spines,
synapses, and other cellular elements). Their abundant endosomes also suggested
their highly phagocytic nature (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). DM tend to form clusters and are found in close
proximity to capillaries. Indeed, around two thirds of the DM observed by
transmission electron microscopy ensheathed the brain vasculature, with
approximately one eighth of them contacting two blood vessels (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>).</p>
<p>Reports from recently published studies point toward a microglial role in the
formation of the blood–brain barrier and maintenance of blood vessels (<xref ref-type="bibr" rid="bibr8-1759091420925335">Dudvarski Stankovic et al.,
2016</xref>; <xref ref-type="bibr" rid="bibr14-1759091420925335">Halder and
Milner, 2019</xref>; <xref ref-type="bibr" rid="bibr26-1759091420925335">Koizumi
et al., 2019</xref>). In this context, the decline of vascular integrity and
microvascular density (<xref ref-type="bibr" rid="bibr61-1759091420925335">Xu
et al., 2017</xref>) accompanied by elevated permeability of blood–brain barrier
seen over the course of aging and during pathological conditions such as chronic
inflammation (<xref ref-type="bibr" rid="bibr5-1759091420925335">da Fonseca et al.,
2014</xref>; <xref ref-type="bibr" rid="bibr16-1759091420925335">Haruwaka
et al., 2019</xref>) hints toward a possible vascular-related role for the
DM.</p>
<p>DM are not always found: their near-total absence in normal adult brain (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>) but
prevalence in pathology suggests that their appearance is either a cause or
consequence (e.g., functional need for the DM) of parenchymal changes. Mouse models
of long-term stress exposure (model of social defeat or chronic unpredictable
stress), aging (14-month-old mice), AD pathology (amyloid precursor
protein-presenilin 1 [APP-PS1] mouse model where APP possesses a double Swedish
mutation and PSEN1 has an exon-9-deleted mutation; <xref ref-type="bibr" rid="bibr21-1759091420925335">Jankowsky et al., 2004</xref>), and fractalkine
signaling deficiency (CX3CR1 knockout mice) were all reported to possess an
increased number of DM in several brain areas such as the hippocampal CA1 region
(<italic>strata lacunosum-moleculare</italic> and <italic>radiatum</italic>),
subgranular layers of cerebral cortex, basolateral nucleus of the amygdala, and
hypothalamic median eminence (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). Because neuronal circuit remodeling is a shared
feature of various pathological conditions, it is likely that DM play a crucial role
in the plasticity of synapses seen in these contexts. This role, however, has yet to
be fully uncovered.</p>
<p>A difference in immunoreactivity to various proteins associated with myeloid cells
can be observed between the DM and the typical microglia. Contrary to the latter, DM
display a low immunoreactivity for homeostatic myeloid cell markers such as ionized
calcium-binding protein (IBA1) and green fluorescent protein (GFP) in the case of
CX3CR1-GFP reporter mice (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht
et al., 2016b</xref>). Their ramified processes encircling various elements of
the synaptic neuropil strongly express phagocytic microglia-specific 4D4 (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>) and the
integrin alpha M subunit (CD11b), a complement receptor 3 element involved in
microglia-dependent synaptic pruning (<xref ref-type="bibr" rid="bibr44-1759091420925335">Schafer et al., 2012</xref>). In addition, in
specific conditions such as AD pathology, the DM were found to express triggering
receptor expressed on myeloid cells 2 (TREM2), particularly when associated with
amyloid β plaques (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al.,
2016b</xref>). These cells also displayed increased phagocytosis of amyloid β as
well as interactions with dystrophic synaptic elements (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). Further
immunohistochemical analyses revealed negative reactivity of DM toward other cell
type markers such as ALDH1L1 (astrocytes), OLIG2 (oligodendrocytes), or CD11c
(dendritic cells; expressed also by the DAM and neurodegenerative phenotype [MGnD];
<xref ref-type="bibr" rid="bibr23-1759091420925335">Keren-Shaul et al.,
2017</xref>; <xref ref-type="bibr" rid="bibr27-1759091420925335">Krasemann
et al., 2017</xref>) or major histocompatibility complex (MHC)II
(antigen-presenting cells; <xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht
et al., 2016b</xref>). No sensitivity was detected also for some markers of
cells with a myeloid origin such as CD206 (perivascular macrophages) and 4C12
(inflammatory monocytes), or the microglial homeostatic marker P2RY12 (purinergic
receptor; <xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al.,
2016b</xref>). Although their origin remains unclear with the evidence currently
available, their immunoreactivity to the phagocytic microglial marker 4D4 and lack
of immunoreactivity to 4C12 suggest an origin from the embryonic yolk sac, similar
to the typical microglia. Supporting this hypothesis, their presence was observed in
the absence of C-C chemokine receptor type 2 (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>), using a knockout mouse
model where infiltrating monocytes do not migrate in the CNS (<xref ref-type="bibr" rid="bibr34-1759091420925335">Mildner et al., 2007</xref>; <xref ref-type="bibr" rid="bibr11-1759091420925335">Gómez-Nicola et al., 2014</xref>).</p>
</sec>
<sec id="sec3-1759091420925335">
<title>Advances in the Dark Microglial Field</title>
<sec id="sec4-1759091420925335">
<title>Development</title>
<p>Although much remains to be discovered, a strong foundation was built with the
ultrastructural description of the DM, therefore stimulating further studies to
elucidate the role of DM in various species and models. Indeed, since the
initial description of the DM by Bisht et al., numerous studies have provided
insightful findings in regard to this microglial subtype. Because one hypothesis
is that DM might contribute to excessive remodeling of synaptic connections
leading to abnormal neuronal circuitry formation, it is crucial to focus on
early periods of brain development where extensive and dynamic
microglia-dependent synaptic remodeling occurs (<xref ref-type="bibr" rid="bibr37-1759091420925335">Paolicelli et al., 2011</xref>; <xref ref-type="bibr" rid="bibr44-1759091420925335">Schafer et al., 2012</xref>).
Interestingly, a recent study hinted to the presence of DM during development
(postnatal day 14), a period undergoing pronounced synaptic plasticity (<xref ref-type="bibr" rid="bibr4-1759091420925335">Chandrasekaran et al.,
2015</xref>), in the rat somatosensory cortex (<xref ref-type="bibr" rid="bibr3-1759091420925335">Calì et al., 2019</xref>). This elegant study
reconstructed in three-dimensions numerous cell types, including microglia, with
the help of serial block-face scanning electron microscopy. From their
reconstruction, the authors discovered that approximately one third of microglia
imaged in Layer VI had a dark cytosol, a characteristic of the intermediate
state (i.e., microglia showing both typical and DM features) and the fully
formed DM defined by Bisht et al. (2016b). It is unclear, however, if these
cells possess other ultrastructural characteristics commonly seen in DM, such as
dilation of the endoplasmic reticulum/Golgi apparatus and altered mitochondria.
The presence of DM in the postnatal developmental stage could be somehow related
to the overabundance of cellular debris and active pruning processes resulting
from dynamic tissue remodeling.</p>
</sec>
<sec id="sec5-1759091420925335">
<title>Psychiatric Disorders</title>
<p>The presence of the DM was also characterized in a mouse model of maternal immune
activation, with the help of transmission electron microscopy (<xref ref-type="bibr" rid="bibr20-1759091420925335">Hui et al., 2018</xref>). This
environmental stressor was previously associated with microglial priming, which
causes their exacerbated inflammatory and nonphysiological response to secondary
challenges, thus promoting a wide range of psychiatric disorder-like behaviors
(<xref ref-type="bibr" rid="bibr32-1759091420925335">Mattei et al.,
2017</xref>; <xref ref-type="bibr" rid="bibr54-1759091420925335">Tay et al.,
2017</xref>). Prenatal administration (at embryonic day 9.5) of
polyinosinic:polycytidylic acid (poly I:C), a molecule mimicking viral
double-stranded RNA infection (<xref ref-type="bibr" rid="bibr48-1759091420925335">Smith et al., 2007</xref>), resulted in a
significant increase of DM density in the hippocampal dentate gyrus (DG)
polymorphic layer of male offspring, without significant differences seen in
females at adulthood (<xref ref-type="bibr" rid="bibr20-1759091420925335">Hui
et al., 2018</xref>). Combined with the noticeable schizophrenia-like
phenotype of male offspring, this finding hints to possible sex-related
differences in the pathophysiological mechanisms that would affect the genesis
of DM or vice versa. The DG plays a key role in learning, memory formation, and
spatial orientation functioning as a niche of neurogenesis throughout life
(<xref ref-type="bibr" rid="bibr49-1759091420925335">Spalding et al.,
2013</xref>; <xref ref-type="bibr" rid="bibr12-1759091420925335">Gonçalves
et al., 2016</xref>). A possibility exists that extensive interactions
between the DM and synapses in the DG could contribute to abnormal functional
connectivity, though additional insights are necessary.</p>
<p>Moreover, a recent <italic>postmortem</italic> study has shown microglial cells
that are ultrastructurally similar to the DM subtype in the prefrontal cortex of
schizophrenia patients (<xref ref-type="bibr" rid="bibr56-1759091420925335">Uranova et al., 2018</xref>). Indeed, these microglia, described as
“dystrophic,” possessed an electron-dense nucleus and cytoplasm filled with
vacuoles (<xref ref-type="bibr" rid="bibr56-1759091420925335">Uranova et al.,
2018</xref>). Interestingly, these cells were located in the white matter,
in close proximity to oligodendrocytes. Considering that these DM were found in
the white matter next to oligodendrocytes (<xref ref-type="bibr" rid="bibr56-1759091420925335">Uranova et al., 2018</xref>), it is likely
that they could have a direct or indirect effect on oligodendrocytic functions
such as myelin formation.</p>
</sec>
<sec id="sec6-1759091420925335">
<title>Neurodegenerative Diseases and Neuroinflammation</title>
<p>Consistent with results of the first article describing DM in AD pathology (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>),
plaque-associated DM-like cells were distinguished in the hippocampus CA1 of
adult APP-PS1 mice using correlative light, transmission and scanning electron
microscopy (<xref ref-type="bibr" rid="bibr9-1759091420925335">El Hajj et al.,
2019</xref>). AD is a progressive neurodegenerative disease that is
characterized by the extracellular accumulation of plaques containing fibrillar
amyloid β and intracellular accumulation of hyperphosphorylated tau protein into
the shape of neurofibrillary tangles (<xref ref-type="bibr" rid="bibr50-1759091420925335">Spires-Jones and Hyman, 2014</xref>).
Resulting neuronal and synaptic loss strongly correlate with the cognitive
impairment and dementia described in AD patients (<xref ref-type="bibr" rid="bibr50-1759091420925335">Spires-Jones and Hyman, 2014</xref>). In the
APP-PS1 mouse model, <xref ref-type="bibr" rid="bibr9-1759091420925335">El Hajj
et al. (2019)</xref> also observed microglia with a preserved, distinct
heterochromatin pattern and a less-dark appearance that suggested the existence
of an intermediate phenotype between the typical and DM (<xref ref-type="bibr" rid="bibr9-1759091420925335">El Hajj et al., 2019</xref>), thus further
supporting the idea that DM might be part of a heterogenous microglial
spectrum.</p>
<p>DM were seen for the first time in PD pathology by examining the
<italic>substantia nigra</italic> of male albino rats that received
subcutaneous injections of rotenone, a broad-spectrum insecticide, piscicide,
and pesticide that inhibits the Complex I of the mitochondrial electron
transport chain (<xref ref-type="bibr" rid="bibr10-1759091420925335">Elgayar
et al., 2018</xref>). PD is a neurodegenerative pathology characterized by,
but not limited to, synaptopathy, presence of misfolded α-synuclein aggregates
(Lewy bodies), and loss of dopaminergic neurons in the <italic>substantia nigra
pars compacta</italic> that result in cognitive and motor deficits (<xref ref-type="bibr" rid="bibr45-1759091420925335">Schirinzi et al., 2016</xref>;
<xref ref-type="bibr" rid="bibr30-1759091420925335">Lecours et al.,
2018</xref>). In this study, <xref ref-type="bibr" rid="bibr10-1759091420925335">Elgayar et al. (2018)</xref> found, using
transmission electron microscopy, the presence of DM near the vasculature, a
feature similar to what was seen previously (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). The authors
identified ultrastructural features normally associated with the DM such as
condensation of the cyto- and nucleoplasm, highly phagocytic processes and
altered mitochondria (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht
et al., 2016b</xref>). However, the study also revealed some apparent
divergences from the DM characterized by Bisht et al. Indeed, the DM described
in this study possessed a heterochromatin pattern similar to what can be seen in
typical microglia (<xref ref-type="bibr" rid="bibr10-1759091420925335">Elgayar
et al., 2018</xref>). Therefore, the DM in the rotenone rat model could
represent an intermediate stage, an analogous phenomenon to what was identified
in an AD mouse model (<xref ref-type="bibr" rid="bibr9-1759091420925335">El Hajj
et al., 2019</xref>). Although their function has not been investigated, the
intermediate and dark microglia could play a role in the synaptic loss seen in
AD and PD, as these cells were previously shown to interact extensively with
synaptic elements.</p>
<p>Following up on these findings, the presence of DM was investigated in the same
brain area as El Hajj et al., in a lipopolysaccharide (LPS)-induced mouse model
of sickness behavior (<xref ref-type="bibr" rid="bibr43-1759091420925335">Savage
et al., 2019b</xref>). The connection between systemic inflammation and
microglial response in sickness behavior has been extensively covered (<xref ref-type="bibr" rid="bibr6-1759091420925335">Dantzer et al., 2008</xref>;
<xref ref-type="bibr" rid="bibr18-1759091420925335">Hoogland et al.,
2015</xref>). While the acute systemic injection of LPS (1 mg/kg) was able
to generate profound alterations of the inflammatory profile and microglial
ultrastructure, no cell harboring ultrastructural features of DM was recognized
at a 24-hour time point. Another condition, a mouse model of Niemann-Pick type
C, where neurodegeneration and inflammation are found, revealed the presence of
the DM. Indeed, <xref ref-type="bibr" rid="bibr22-1759091420925335">Kavetsky
et al. (2019)</xref> investigated NPC<sup>nmf164</sup> mice given for 5
weeks either a Western diet or a regular diet. Niemann-Pick type C is a genetic
condition with mutations in the NPC genes (<italic>Npc1/2</italic>), which most
notably lead to dysfunctional lysosomes (<xref ref-type="bibr" rid="bibr59-1759091420925335">Wheeler and Sillence, 2019</xref>). While
looking at microglia in the molecular layer of the cerebellum of both males and
females with transmission electron microscopy, the authors identified DM
processes interacting with synapses, a phenomenon especially seen in the mice
given a Western diet (<xref ref-type="bibr" rid="bibr22-1759091420925335">Kavetsky et al., 2019</xref>). This finding indicates that Western diet
exacerbates the inflammation found in this mouse model and causes alterations
sufficient to generate DM. Although DM are frequently found in an inflammatory
brain parenchyma like that of NPC<sup>nmf164</sup> mice, it is not always the
case (e.g., in acute inflammation induced by LPS injection), suggesting that the
genesis of the DM might depend on a specific mechanism or pathway related to
inflammation, or require chronic challenges.</p>
</sec>
<sec id="sec7-1759091420925335">
<title>Beyond Electron Microscopy</title>
<p>Electron microscopy is not the only tool that was used to characterize the DM.
Indeed, <xref ref-type="bibr" rid="bibr39-1759091420925335">Pedicone et al.
(2020)</xref> performed flow cytometry experiments, gating with CD11b and
TREM2, to determine if DM were present in the cerebral cortex of 4-month-old
C56BL/6 mice injected biweekly for 3 weeks with a pan-SH-2 containing inositol
5' polyphosphatase (SHIP)1/2 inhibitor, K161. The protein SHIP-1 is able to bind
to the adaptor protein DAP12 resulting in the inhibition of the TREM2 signaling
pathway (<xref ref-type="bibr" rid="bibr36-1759091420925335">Nizami et al.,
2019</xref>). Therefore, modulating SHIP1/2 pathway to prevent this
inhibition could be useful for the treatment of neurodegenerative diseases where
TREM2 was shown to have a beneficial effect (<xref ref-type="bibr" rid="bibr33-1759091420925335">Melchior et al., 2010</xref>; <xref ref-type="bibr" rid="bibr57-1759091420925335">Wang et al., 2015</xref>).
TREM2 was previously identified as a key protein for the genesis of various
microglial subtypes including the DAM and MGnD (<xref ref-type="bibr" rid="bibr23-1759091420925335">Keren-Shaul et al., 2017</xref>; <xref ref-type="bibr" rid="bibr27-1759091420925335">Krasemann et al.,
2017</xref>). CD11b, an essential component of the complement receptor 3
involved in synaptic pruning, is a protein expressed by both dark and typical
microglial cells (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht
et al., 2016b</xref>; <xref ref-type="bibr" rid="bibr19-1759091420925335">Hopperton et al., 2018</xref>). The study showed no difference of CD11b and
TREM2 mean fluorescence intensity between controls and K161-treated animals and
therefore concludes that DM do not emerge as a result of the K161 treatment
(Pedicone et al., 2020). However, in this case, the interpretation of these
results does not necessarily take into account all information concerning the
DM. TREM2 and CD11b are not exclusively expressed by the DM and therefore cannot
be used as specific markers for this subtype (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>). Moreover, while it
is possible to determine the immunoreactivity of a cell for a particular protein
with electron microscopy, it is difficult, albeit close to impossible, to
quantify with exactitude immunoreactivity levels. Therefore, the levels of
proteins such as CD11b and TREM2 that are expressed by the DM versus the typical
microglia or other subtypes are yet unknown, and their varying expression cannot
be currently used as a tool to distinguish other populations from the DM. The
expression of TREM2 by the DM was identified in an APP-PS1 model but not
characterized yet in other models. It would be crucial to determine, using
electron microscopy, if this subtype expresses CD11b and TREM2 in the
K161-treated mice for a full interpretation of the results as well as assess the
specificity of the protein to DM (see <xref ref-type="table" rid="table1-1759091420925335">Table 1</xref> for a full summary of the
published dark microglial studies to the authors knowledge).</p>
</sec>
</sec>
<sec id="sec8-1759091420925335" sec-type="conclusions">
<title>Conclusion</title>
<p>Microglial heterogeneity has been a topic of interest in the past few years, and one
of these subtypes, the DM, has been no exception. These unique microglial cells
first described using transmission electron microscopy are found in numerous
pathological conditions where synaptic plasticity is heightened, such as in mouse
models of AD, chronic stress, fractalkine signaling deficiency, and aging (<xref ref-type="bibr" rid="bibr2-1759091420925335">Bisht et al., 2016b</xref>).
Recently, they have also been identified in rats and humans (<xref ref-type="bibr" rid="bibr10-1759091420925335">Elgayar et al., 2018</xref>; <xref ref-type="bibr" rid="bibr56-1759091420925335">Uranova et al., 2018</xref>; <xref ref-type="bibr" rid="bibr3-1759091420925335">Calì et al., 2019</xref>), suggesting that this
subtype is conserved across species. Studying these cells and learning more about
their function could, in the future, be applied to the human condition. Indeed,
these cells that are associated with ultrastructural features of oxidative stress
seem to interact excessively with synaptic elements, suggesting that their presence
could exacerbate the synaptic loss seen in pathology. Modulating these cells could
hence be a potential new therapeutic target for neurodegenerative disease such as AD
and PD.</p>
<p>While electron microscopy allows to provide an in-depth ultrastructural analysis of
the DM, many questions remain to be answered due to technical limitation. Indeed,
their unique ultrastructural feature, most notably their dark cyto- and nucleoplasm
as well as the lack of chromatin pattern, is the only way to properly identify these
cells currently. Therefore, electron microscopy is the only tool that can be used to
characterize these cells.</p>
<p>Fortunately, new electron microscopy techniques, such as serial-block face and
focused ion beam scanning electron microscopy, that can reconstruct taken images in
three dimensions, have been developed and can help answer some of the remaining
questions regarding the DM. Identifying a specific marker for this subtype, which
could be used to perform high-throughput molecular analyses and create transgenic
models, will be crucial for the future of the DM field. With these transgenic
models, it would be possible for researchers to isolate these cells and further
process them using state-of-the-art RNA sequencing for instance to learn more about
their function, especially in regard to inflammation, the vasculature and synapses,
and their altered transcriptome compared with the typical microglia (e.g., determine
if they possess a more pro- or anti-inflammatory profile). Moreover, although some
clues have already been provided regarding the DM origin (e.g., immunopositivity for
4D4 and immunonegativity for 4C12, as well as presence in C-C chemokine receptor
type 2 knockout mice), determining their gene expression could provide more
certitude as to whether they come from the periphery or the embryonic yolk sac. In
addition, dynamic analysis of DM process motility using <italic>in vivo</italic>
two-photon microscopy could be useful to determine how their hyperramifications seen
in electron microscopy interact with neurons and synapses.</p>
</sec>
</body>
<back>
<sec>
<title>Authors' Note</title>
<p>Marie-Ève Tremblay is also affiliated with Division of Medical Sciences, University
of Victoria.</p>
</sec>
<sec id="sec9-1759091420925335">
<title>Declaration of Conflicting Interests</title>
<p>The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p>
</sec>
<sec id="sec10-1759091420925335">
<title>Funding</title>
<p>The author(s) disclosed receipt of the following financial support for the research,
authorship, and/or publication of this article: M.-K. S.-P. holds a Canadian
Institute of Health Research and a Fonds de recherche du Québec-Santé doctoral
scholarship. E. S. holds a national scholarship program of the Slovak Republic
provided by Slovak Academic Information Agency. M.-E. T. holds a Tier II Canada
Research Chair in Neurobiology of Aging and Cognition.</p>
</sec>
<sec>
<title>ORCID iD</title>
<p>Marie-Ève Tremblay <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-2863-9626">https://orcid.org/0000-0003-2863-9626</ext-link></p>
</sec>
<ref-list content-type="nameDate">
<title>References</title>
<ref id="bibr1-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Lacoste</surname><given-names>B.</given-names></name><name><surname>Tremblay</surname><given-names>M.-È.</given-names></name></person-group> (<year>2016</year>a). <article-title>Dark microglia: Why are
they dark?</article-title>
<source/>Commun Integr Biol, <volume>9</volume>,
<fpage>e1230575</fpage>
<pub-id pub-id-type="doi">10.1080/19420889.2016.1230575</pub-id><pub-id pub-id-type="pmid">28042375</pub-id></mixed-citation>
</ref>
<ref id="bibr2-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Sharma</surname><given-names>K. P.</given-names></name><name><surname>Lecours</surname><given-names>C.</given-names></name><name><surname>Gabriela Sánchez</surname><given-names>M.</given-names></name><name><surname>El Hajj</surname><given-names>H.</given-names></name><name><surname>Milior</surname><given-names>G.</given-names></name></person-group>, <etal>et al</etal> (<year>2016</year>b). <article-title>Dark
microglia: A new phenotype predominantly associated with pathological
states</article-title>. <source/>Glia, <volume>64</volume>,
<fpage>826</fpage>–<lpage>839</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22966</pub-id><pub-id pub-id-type="pmid">26847266</pub-id></mixed-citation>
</ref>
<ref id="bibr3-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calì</surname><given-names>C.</given-names></name><name><surname>Agus</surname><given-names>M.</given-names></name><name><surname>Kare</surname><given-names>K.</given-names></name><name><surname>Boges</surname><given-names>D. J.</given-names></name><name><surname>Lehväslaiho</surname><given-names>H.</given-names></name><name><surname>Hadwiger</surname><given-names>M.</given-names></name></person-group>, <etal>et al</etal> (<year>2019</year>). <article-title>3D
cellular reconstruction of cortical glia and parenchymal morphometric
analysis from serial block-face electron microscopy of juvenile
rat</article-title>. <source/>Prog Neurobiol, <volume>183</volume>,
<fpage>101696</fpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2019.101696</pub-id><pub-id pub-id-type="pmid">31550514</pub-id></mixed-citation>
</ref>
<ref id="bibr4-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>S.</given-names></name><name><surname>Navlakha</surname><given-names>S.</given-names></name><name><surname>Audette</surname><given-names>N. J.</given-names></name><name><surname>McCreary</surname><given-names>D. D.</given-names></name><name><surname>Suhan</surname><given-names>J.</given-names></name><name><surname>Bar-Joseph</surname><given-names>Z.</given-names></name></person-group>, <etal>et al</etal> (<year>2015</year>).
<article-title>Unbiased, high-throughput electron microscopy analysis of
experience-dependent synaptic changes in the neocortex</article-title>.
<source/>J Neurosci, <volume>35</volume>,
<fpage>16450</fpage>–<lpage>16462</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1573-15.2015</pub-id><pub-id pub-id-type="pmid">26674870</pub-id></mixed-citation>
</ref>
<ref id="bibr5-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Fonseca</surname><given-names>A. C. C.</given-names></name><name><surname>Matias</surname><given-names>D.</given-names></name><name><surname>Garcia</surname><given-names>C.</given-names></name><name><surname>Amaral</surname><given-names>R.</given-names></name><name><surname>Geraldo</surname><given-names>L. H.</given-names></name><name><surname>Freitas</surname><given-names>C.</given-names></name></person-group>, <etal>et al</etal> (<year>2014</year>). <article-title>The
impact of microglial activation on blood-brain barrier in brain
diseases</article-title>. <source/>Front Cell Neurosci,
<volume>8</volume>, 362. <pub-id pub-id-type="doi">10.3389/fncel.2014.00362</pub-id></mixed-citation>
</ref>
<ref id="bibr6-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R.</given-names></name><name><surname>O’Connor</surname><given-names>J. C.</given-names></name><name><surname>Freund</surname><given-names>G. G.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name></person-group> (<year>2008</year>). <article-title>From inflammation to
sickness and depression: When the immune system subjugates the
brain</article-title>. <source/>Nat Rev Neurosci,
<volume>9</volume>, <fpage>46</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2297</pub-id><pub-id pub-id-type="pmid">18073775</pub-id></mixed-citation>
</ref>
<ref id="bibr7-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deczkowska</surname><given-names>A.</given-names></name><name><surname>Keren-Shaul</surname><given-names>H.</given-names></name><name><surname>Weiner</surname><given-names>A.</given-names></name><name><surname>Colonna</surname><given-names>M.</given-names></name><name><surname>Schwartz</surname><given-names>M.</given-names></name><name><surname>Amit</surname><given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Disease-associated
microglia: A universal immune sensor of neurodegeneration</article-title>.
<source/>Cell, <volume>173</volume>,
<fpage>1073</fpage>–<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.05.003</pub-id><pub-id pub-id-type="pmid">29775591</pub-id></mixed-citation>
</ref>
<ref id="bibr8-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudvarski Stankovic</surname><given-names>N.</given-names></name><name><surname>Teodorczyk</surname><given-names>M.</given-names></name><name><surname>Ploen</surname><given-names>R.</given-names></name><name><surname>Zipp</surname><given-names>F.</given-names></name><name><surname>Schmidt</surname><given-names>M. H. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Microglia-blood vessel
interactions: A double-edged sword in brain pathologies</article-title>.
<source/>Acta Neuropathol, <volume>131</volume>,
<fpage>347</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-015-1524-y</pub-id><pub-id pub-id-type="pmid">26711460</pub-id></mixed-citation>
</ref>
<ref id="bibr9-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Hajj</surname><given-names>H.</given-names></name><name><surname>Savage</surname><given-names>J. C.</given-names></name><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Parent</surname><given-names>M.</given-names></name><name><surname>Vallières</surname><given-names>L.</given-names></name><name><surname>Rivest</surname><given-names>S.</given-names></name></person-group>, <etal>et al</etal> (<year>2019</year>).
<article-title>Ultrastructural evidence of microglial heterogeneity in
Alzheimer’s disease amyloid pathology</article-title>. <source/>J
Neuroinflammation, <volume>16</volume>, <fpage>87</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-019-1473-9</pub-id><pub-id pub-id-type="pmid">30992040</pub-id></mixed-citation>
</ref>
<ref id="bibr10-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elgayar</surname><given-names>S. A. M.</given-names></name><name><surname>Abdel-Hafez</surname><given-names>A. A. M.</given-names></name><name><surname>Gomaa</surname><given-names>A. M. S.</given-names></name><name><surname>Elsherif</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Vulnerability of glia and
vessels of rat substantia nigra in rotenone Parkinson model</article-title>.
<source/>Ultrastruct Pathol, <volume>42</volume>,
<fpage>181</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1080/01913123.2017.1422066</pub-id><pub-id pub-id-type="pmid">29466086</pub-id></mixed-citation>
</ref>
<ref id="bibr11-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Nicola</surname><given-names>D.</given-names></name><name><surname>Schetters</surname><given-names>S. T.</given-names></name><name><surname>Hugh Perry</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>Differential role of CCR2 in
the dynamics of microglia and perivascular macrophages during prion
disease</article-title>. <source/>Glia, <volume>62</volume>,
<fpage>1041</fpage>–<lpage>1052</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22660</pub-id><pub-id pub-id-type="pmid">24648328</pub-id></mixed-citation>
</ref>
<ref id="bibr12-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonçalves</surname><given-names>J. T.</given-names></name><name><surname>Schafer</surname><given-names>S. T.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Adult neurogenesis in the
hippocampus: From stem cells to behavior</article-title>.
<source/>Cell, <volume>167</volume>,
<fpage>897</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.021</pub-id><pub-id pub-id-type="pmid">27814520</pub-id></mixed-citation>
</ref>
<ref id="bibr13-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagemeyer</surname><given-names>N.</given-names></name><name><surname>Hanft</surname><given-names>K.-M.</given-names></name><name><surname>Akriditou</surname><given-names>M.-A.</given-names></name><name><surname>Unger</surname><given-names>N.</given-names></name><name><surname>Park</surname><given-names>E. S.</given-names></name><name><surname>Stanley</surname><given-names>E. R.</given-names></name></person-group>, <etal>et al</etal> (<year>2017</year>).
<article-title>Microglia contribute to normal myelinogenesis and to
oligodendrocyte progenitor maintenance during adulthood</article-title>.
<source/>Acta Neuropathol, <volume>134</volume>,
<fpage>441</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-017-1747-1</pub-id><pub-id pub-id-type="pmid">28685323</pub-id></mixed-citation>
</ref>
<ref id="bibr14-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halder</surname><given-names>S. K.</given-names></name><name><surname>Milner</surname><given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>A critical role for
microglia in maintaining vascular integrity in the hypoxic spinal
cord</article-title>. <source/>PNAS, <volume>116</volume>,
<fpage>26029</fpage>–<lpage>26037</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1912178116</pub-id><pub-id pub-id-type="pmid">31772011</pub-id></mixed-citation>
</ref>
<ref id="bibr15-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>T. R.</given-names></name><name><surname>Dufort</surname><given-names>C.</given-names></name><name><surname>Dissing-Olesen</surname><given-names>L.</given-names></name><name><surname>Giera</surname><given-names>S.</given-names></name><name><surname>Young</surname><given-names>A.</given-names></name><name><surname>Wysoker</surname><given-names>A.</given-names></name></person-group>, <etal>et al</etal> (<year>2019</year>).
<article-title>Single-cell RNA sequencing of microglia throughout the mouse
lifespan and in the injured brain reveals complex cell-state
changes</article-title>. <source/>Immunity, <volume>50</volume>,
<fpage>253</fpage>–<lpage>271</lpage>.e6. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.11.004</pub-id><pub-id pub-id-type="pmid">30471926</pub-id></mixed-citation>
</ref>
<ref id="bibr16-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haruwaka</surname><given-names>K.</given-names></name><name><surname>Ikegami</surname><given-names>A.</given-names></name><name><surname>Tachibana</surname><given-names>Y.</given-names></name><name><surname>Ohno</surname><given-names>N.</given-names></name><name><surname>Konishi</surname><given-names>H.</given-names></name><name><surname>Hashimoto</surname><given-names>A.</given-names></name></person-group>, <etal>et al</etal> (<year>2019</year>). <article-title>Dual
microglia effects on blood brain barrier permeability induced by systemic
inflammation</article-title>. <source/>Nat Commun,
<volume>10</volume>, <issue>1</issue>–<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-13812-z</pub-id><pub-id pub-id-type="pmid">30604743</pub-id></mixed-citation>
</ref>
<ref id="bibr17-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Beja-Glasser</surname><given-names>V. F.</given-names></name><name><surname>Nfonoyim</surname><given-names>B. M.</given-names></name><name><surname>Frouin</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Ramakrishnan</surname><given-names>S.</given-names></name></person-group>, <etal>et al</etal> (<year>2016</year>).
<article-title>Complement and microglia mediate early synapse loss in
Alzheimer mouse models</article-title>. <source/>Science,
<volume>352</volume>, <fpage>712</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad8373</pub-id><pub-id pub-id-type="pmid">27033548</pub-id></mixed-citation>
</ref>
<ref id="bibr18-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoogland</surname><given-names>I. C. M.</given-names></name><name><surname>Houbolt</surname><given-names>C.</given-names></name><name><surname>van Westerloo</surname><given-names>D. J.</given-names></name><name><surname>van Gool</surname><given-names>W. A.</given-names></name><name><surname>van de Beek</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Systemic inflammation and
microglial activation: Systematic review of animal
experiments</article-title>. <source/>J Neuroinflammation,
<volume>12</volume>, <fpage>114</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-015-0332-6</pub-id><pub-id pub-id-type="pmid">26048578</pub-id></mixed-citation>
</ref>
<ref id="bibr19-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopperton</surname><given-names>K. E.</given-names></name><name><surname>Mohammad</surname><given-names>D.</given-names></name><name><surname>Trépanier</surname><given-names>M. O.</given-names></name><name><surname>Giuliano</surname><given-names>V.</given-names></name><name><surname>Bazinet</surname><given-names>R. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Markers of microglia in
post-mortem brain samples from patients with Alzheimer’s disease: A
systematic review</article-title>. <source/>Mol Psychiatry,
<volume>23</volume>, <fpage>177</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2017.246</pub-id><pub-id pub-id-type="pmid">29230021</pub-id></mixed-citation>
</ref>
<ref id="bibr20-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>C. W.</given-names></name><name><surname>St-Pierre</surname><given-names>A.</given-names></name><name><surname>El Hajj</surname><given-names>H.</given-names></name><name><surname>Remy</surname><given-names>Y.</given-names></name><name><surname>Hébert</surname><given-names>S. S.</given-names></name><name><surname>Luheshi</surname><given-names>G. N.</given-names></name></person-group>, <etal>et al</etal> (<year>2018</year>).
<article-title>Prenatal immune challenge in mice leads to partly
sex-dependent behavioral, microglial, and molecular abnormalities associated
with schizophrenia</article-title>. <source/>Front Mol Neurosci,
<volume>11</volume>, <fpage>13</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2018.00013</pub-id><pub-id pub-id-type="pmid">29472840</pub-id></mixed-citation>
</ref>
<ref id="bibr21-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankowsky</surname><given-names>J. L.</given-names></name><name><surname>Fadale</surname><given-names>D. J.</given-names></name><name><surname>Anderson</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>G. M.</given-names></name><name><surname>Gonzales</surname><given-names>V.</given-names></name><name><surname>Jenkins</surname><given-names>N. A.</given-names></name></person-group>, <etal>et al</etal> (<year>2004</year>). <article-title>Mutant
presenilins specifically elevate the levels of the 42 residue beta-amyloid
peptide in vivo: Evidence for augmentation of a 42-specific gamma
secretase</article-title>. <source/>Hum Mol Genet,
<volume>13</volume>, <fpage>159</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh019</pub-id><pub-id pub-id-type="pmid">14645205</pub-id></mixed-citation>
</ref>
<ref id="bibr22-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavetsky</surname><given-names>L.</given-names></name><name><surname>Green</surname><given-names>K. K.</given-names></name><name><surname>Boyle</surname><given-names>B. R.</given-names></name><name><surname>Yousufzai</surname><given-names>F. A. K.</given-names></name><name><surname>Padron</surname><given-names>Z. M.</given-names></name><name><surname>Melli</surname><given-names>S. E.</given-names></name></person-group>, <etal>et al</etal> (<year>2019</year>).
<article-title>Increased interactions and engulfment of dendrites by
microglia precede Purkinje cell degeneration in a mouse model of Niemann
Pick type-C</article-title>. <source/>Sci Rep, <volume>9</volume>
<pub-id pub-id-type="doi">10.1038/s41598-019-51246-1</pub-id></mixed-citation>
</ref>
<ref id="bibr23-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren-Shaul</surname><given-names>H.</given-names></name><name><surname>Spinrad</surname><given-names>A.</given-names></name><name><surname>Weiner</surname><given-names>A.</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O.</given-names></name><name><surname>Dvir-Szternfeld</surname><given-names>R.</given-names></name><name><surname>Ulland</surname><given-names>T. K.</given-names></name></person-group>, <etal>et al</etal> (<year>2017</year>). <article-title>A
unique microglia type associated with restricting development of Alzheimer’s
disease</article-title>. <source/>Cell, <volume>169</volume>,
<fpage>1276</fpage>–<lpage>1290</lpage>.e17. <pub-id pub-id-type="doi">10.1016/j.cell.2017.05.018</pub-id><pub-id pub-id-type="pmid">28602351</pub-id></mixed-citation>
</ref>
<ref id="bibr24-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kettenmann</surname><given-names>H.</given-names></name><name><surname>Kirchhoff</surname><given-names>F.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia: New roles for the
synaptic stripper</article-title>. <source/>Neuron,
<volume>77</volume>, <fpage>10</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.12.023</pub-id><pub-id pub-id-type="pmid">23312512</pub-id></mixed-citation>
</ref>
<ref id="bibr25-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinhans</surname><given-names>N. M.</given-names></name><name><surname>Reiter</surname><given-names>M. A.</given-names></name><name><surname>Neuhaus</surname><given-names>E.</given-names></name><name><surname>Pauley</surname><given-names>G.</given-names></name><name><surname>Martin</surname><given-names>N.</given-names></name><name><surname>Dager</surname><given-names>S.</given-names></name></person-group>, <etal>et al</etal> (<year>2016</year>).
<article-title>Subregional differences in intrinsic amygdala
hyperconnectivity and hypoconnectivity in autism spectrum
disorder</article-title>. <source/>Autism Res, <volume>9</volume>,
<fpage>760</fpage>–<lpage>772</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1589</pub-id><pub-id pub-id-type="pmid">26666502</pub-id></mixed-citation>
</ref>
<ref id="bibr26-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>T.</given-names></name><name><surname>Kerkhofs</surname><given-names>D.</given-names></name><name><surname>Mizuno</surname><given-names>T.</given-names></name><name><surname>Steinbusch</surname><given-names>H. W. M.</given-names></name><name><surname>Foulquier</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Vessel-associated immune
cells in cerebrovascular diseases: From perivascular macrophages to
vessel-associated microglia</article-title>. <source/>Front
Neurosci, <volume>13</volume>, 1291. <pub-id pub-id-type="doi">10.3389/fnins.2019.01291</pub-id></mixed-citation>
</ref>
<ref id="bibr27-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasemann</surname><given-names>S.</given-names></name><name><surname>Madore</surname><given-names>C.</given-names></name><name><surname>Cialic</surname><given-names>R.</given-names></name><name><surname>Baufeld</surname><given-names>C.</given-names></name><name><surname>Calcagno</surname><given-names>N.</given-names></name><name><surname>El Fatimy</surname><given-names>R.</given-names></name></person-group>, <etal>et al</etal> (<year>2017</year>). <article-title>The
TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional
microglia in neurodegenerative diseases</article-title>.
<source/>Immunity, <volume>47</volume>,
<fpage>566</fpage>–<lpage>581</lpage>.e9. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.08.008</pub-id><pub-id pub-id-type="pmid">28930663</pub-id></mixed-citation>
</ref>
<ref id="bibr28-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lardenoije</surname><given-names>R.</given-names></name><name><surname>Iatrou</surname><given-names>A.</given-names></name><name><surname>Kenis</surname><given-names>G.</given-names></name><name><surname>Kompotis</surname><given-names>K.</given-names></name><name><surname>Steinbusch</surname><given-names>H. W. M.</given-names></name><name><surname>Mastroeni</surname><given-names>D.</given-names></name></person-group>, <etal>et al</etal> (<year>2015</year>). <article-title>The
epigenetics of aging and neurodegeneration</article-title>. <source/>Prog
Neurobiol, <volume>131</volume>,
<fpage>21</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.05.002</pub-id><pub-id pub-id-type="pmid">26072273</pub-id></mixed-citation>
</ref>
<ref id="bibr29-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>L. J.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Dri</surname><given-names>P.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>1990</year>). <article-title>Heterogeneity in the
distribution and morphology of microglia in the normal adult mouse
brain</article-title>. <source/>Neuroscience, <volume>39</volume>,
<fpage>151</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(90)90229-w</pub-id><pub-id pub-id-type="pmid">2089275</pub-id></mixed-citation>
</ref>
<ref id="bibr30-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lecours</surname><given-names>C.</given-names></name><name><surname>Bordeleau</surname><given-names>M.</given-names></name><name><surname>Cantin</surname><given-names>L.</given-names></name><name><surname>Parent</surname><given-names>M.</given-names></name><name><surname>Paolo</surname><given-names>T. D.</given-names></name><name><surname>Tremblay</surname><given-names>M.-È.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglial implication in
Parkinson’s disease: Loss of beneficial physiological roles or gain of
inflammatory functions?</article-title>
<source/>Front Cell Neurosci, <volume>12</volume>, 282. <pub-id pub-id-type="doi">10.3389/fncel.2018.00282</pub-id></mixed-citation>
</ref>
<ref id="bibr31-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Darmanis</surname><given-names>S.</given-names></name><name><surname>Neff</surname><given-names>N. F.</given-names></name><name><surname>Okamoto</surname><given-names>J.</given-names></name></person-group>, <etal>et al</etal> (<year>2019</year>).
<article-title>Developmental heterogeneity of microglia and brain myeloid
cells revealed by deep single-cell RNA sequencing</article-title>.
<source/>Neuron, <volume>101</volume>,
<fpage>207</fpage>–<lpage>223</lpage>.e10. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.12.006</pub-id><pub-id pub-id-type="pmid">30606613</pub-id></mixed-citation>
</ref>
<ref id="bibr32-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>D.</given-names></name><name><surname>Ivanov</surname><given-names>A.</given-names></name><name><surname>Ferrai</surname><given-names>C.</given-names></name><name><surname>Jordan</surname><given-names>P.</given-names></name><name><surname>Guneykaya</surname><given-names>D.</given-names></name><name><surname>Buonfiglioli</surname><given-names>A.</given-names></name></person-group>, <etal>et al</etal> (<year>2017</year>).
<article-title>Maternal immune activation results in complex microglial
transcriptome signature in the adult offspring that is reversed by
minocycline treatment</article-title>. <source/>Transl Psychiatry,
<volume>7</volume>, <fpage>e1120</fpage>–<lpage>e1120</lpage>. <pub-id pub-id-type="doi">10.1038/tp.2017.80</pub-id>.<pub-id pub-id-type="pmid">28485733</pub-id></mixed-citation>
</ref>
<ref id="bibr33-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melchior</surname><given-names>B.</given-names></name><name><surname>Garcia</surname><given-names>A. E.</given-names></name><name><surname>Hsiung</surname><given-names>B.-K.</given-names></name><name><surname>Lo</surname><given-names>K. M.</given-names></name><name><surname>Doose</surname><given-names>J. M.</given-names></name><name><surname>Thrash</surname><given-names>J. C.</given-names></name></person-group>, <etal>et al</etal> (<year>2010</year>). <article-title>Dual
induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid
transgenic mice: Implications for vaccine-based therapies for Alzheimer’s
disease</article-title>. <source/>ASN Neuro, <volume>2</volume>,
<fpage>e00037</fpage>
<pub-id pub-id-type="doi">10.1042/AN20100010</pub-id><pub-id pub-id-type="pmid">20640189</pub-id></mixed-citation>
</ref>
<ref id="bibr34-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mildner</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>H.</given-names></name><name><surname>Nitsche</surname><given-names>M.</given-names></name><name><surname>Merkler</surname><given-names>D.</given-names></name><name><surname>Hanisch</surname><given-names>U.-K.</given-names></name><name><surname>Mack</surname><given-names>M.</given-names></name></person-group>, <etal>et al</etal> (<year>2007</year>).
<article-title>Microglia in the adult brain arise from Ly-6ChiCCR2+
monocytes only under defined host conditions</article-title>. <source/>Nat
Neurosci, <volume>10</volume>,
<fpage>1544</fpage>–<lpage>1553</lpage>. <pub-id pub-id-type="doi">10.1038/nn2015</pub-id><pub-id pub-id-type="pmid">18026096</pub-id></mixed-citation>
</ref>
<ref id="bibr35-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>L. B.</given-names></name><name><surname>Graeber</surname><given-names>M. B.</given-names></name></person-group> (<year>2004</year>). <article-title>The facial nerve axotomy
model</article-title>. <source/>Brain Res Rev, <volume>44</volume>,
<fpage>154</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2003.11.004</pub-id><pub-id pub-id-type="pmid">15003391</pub-id></mixed-citation>
</ref>
<ref id="bibr36-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nizami</surname><given-names>S.</given-names></name><name><surname>Hall-Roberts</surname><given-names>H.</given-names></name><name><surname>Warrier</surname><given-names>S.</given-names></name><name><surname>Cowley</surname><given-names>S. A.</given-names></name><name><surname>Di Daniel</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>Microglial inflammation and
phagocytosis in Alzheimer’s disease: Potential therapeutic
targets</article-title>. <source/>Br J Pharmacol,
<volume>176</volume>, <fpage>3515</fpage>–<lpage>3532</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14618</pub-id><pub-id pub-id-type="pmid">30740661</pub-id></mixed-citation>
</ref>
<ref id="bibr37-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Scianni</surname><given-names>M.</given-names></name><name><surname>Panzanelli</surname><given-names>P.</given-names></name></person-group>, <etal>et al</etal> (<year>2011</year>).
<article-title>Synaptic pruning by microglia is necessary for normal brain
development</article-title>. <source/>Science, <volume>333</volume>,
<fpage>1456</fpage>–<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.1126/science.1202529</pub-id><pub-id pub-id-type="pmid">21778362</pub-id></mixed-citation>
</ref>
<ref id="bibr38-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkhurst</surname><given-names>C. N.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Ninan</surname><given-names>I.</given-names></name><name><surname>Savas</surname><given-names>J. N.</given-names></name><name><surname>Yates</surname><given-names>J. R.</given-names></name><name><surname>Lafaille</surname><given-names>J. J.</given-names></name></person-group>, <etal>et al</etal> (<year>2013</year>).
<article-title>Microglia promote learning-dependent synapse formation
through BDNF</article-title>. <source/>Cell, <volume>155</volume>,
<fpage>1596</fpage>–<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.030</pub-id><pub-id pub-id-type="pmid">24360280</pub-id></mixed-citation>
</ref>
<ref id="bibr39-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedicone</surname><given-names>C.</given-names></name><name><surname>Fernandes</surname><given-names>S.</given-names></name><name><surname>Dungan</surname><given-names>O. M.</given-names></name><name><surname>Dormann</surname><given-names>S. M.</given-names></name><name><surname>Viernes</surname><given-names>D. R.</given-names></name><name><surname>Adhikari</surname><given-names>A. A.</given-names></name></person-group>, <etal>et al</etal> (<year>2020</year>).
<article-title>Pan-SHIP1/2 inhibitors promote microglia effector functions
essential for CNS homeostasis</article-title>. <source/>J Cell Sci,
<volume>133</volume>
<pub-id pub-id-type="doi">10.1242/jcs.238030</pub-id></mixed-citation>
</ref>
<ref id="bibr40-1759091420925335">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A.</given-names></name><name><surname>Palay</surname><given-names>S. L.</given-names></name><name><surname>deF Webster</surname><given-names>H.</given-names></name></person-group> (<year>1991</year>). <source/>The fine structure of the nervous
system: Neurons and their supporting cells. <publisher-name>Oxford
University Press</publisher-name>.</mixed-citation>
</ref>
<ref id="bibr41-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salter</surname><given-names>M. W.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Microglia emerge as central
players in brain disease</article-title>. <source/>Nat Med,
<volume>23</volume>, <fpage>1018</fpage>–<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4397</pub-id><pub-id pub-id-type="pmid">28886007</pub-id></mixed-citation>
</ref>
<ref id="bibr42-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>J. C.</given-names></name><name><surname>Carrier</surname><given-names>M.</given-names></name><name><surname>Tremblay</surname><given-names>M.-È.</given-names></name></person-group> (<year>2019</year>a). <article-title>Morphology of microglia
across contexts of health and disease</article-title>. <source/>Methods Mol
Biol, <volume>2034</volume>, <fpage>13</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="doi">10.1007/978-1-4939-9658-2_2</pub-id><pub-id pub-id-type="pmid">31392674</pub-id></mixed-citation>
</ref>
<ref id="bibr43-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>J. C.</given-names></name><name><surname>St-Pierre</surname><given-names>M.-K.</given-names></name><name><surname>Hui</surname><given-names>C. W.</given-names></name><name><surname>Tremblay</surname><given-names>M.-E.</given-names></name></person-group> (<year>2019</year>b). <article-title>Microglial ultrastructure
in the hippocampus of a lipopolysaccharide-induced sickness mouse
model</article-title>. <source/>Front Neurosci, <volume>13</volume>,
<fpage>1340</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2019.01340</pub-id><pub-id pub-id-type="pmid">31920505</pub-id></mixed-citation>
</ref>
<ref id="bibr44-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>D. P.</given-names></name><name><surname>Lehrman</surname><given-names>E. K.</given-names></name><name><surname>Kautzman</surname><given-names>A. G.</given-names></name><name><surname>Koyama</surname><given-names>R.</given-names></name><name><surname>Mardinly</surname><given-names>A. R.</given-names></name><name><surname>Yamasaki</surname><given-names>R.</given-names></name></person-group>, <etal>et al</etal> (<year>2012</year>).
<article-title>Microglia sculpt postnatal neural circuits in an activity and
complement-dependent manner</article-title>. <source/>Neuron,
<volume>74</volume>, <fpage>691</fpage>–<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.026</pub-id><pub-id pub-id-type="pmid">22632727</pub-id></mixed-citation>
</ref>
<ref id="bibr45-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirinzi</surname><given-names>T.</given-names></name><name><surname>Madeo</surname><given-names>G.</given-names></name><name><surname>Martella</surname><given-names>G.</given-names></name><name><surname>Maltese</surname><given-names>M.</given-names></name><name><surname>Picconi</surname><given-names>B.</given-names></name><name><surname>Calabresi</surname><given-names>P.</given-names></name></person-group>, <etal>et al</etal> (<year>2016</year>). <article-title>Early
synaptic dysfunction in Parkinson’s disease: Insights from animal
models</article-title>. <source/>Mov Disord, <volume>31</volume>,
<fpage>802</fpage>–<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26620</pub-id><pub-id pub-id-type="pmid">27193205</pub-id></mixed-citation>
</ref>
<ref id="bibr46-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellgren</surname><given-names>C. M.</given-names></name><name><surname>Gracias</surname><given-names>J.</given-names></name><name><surname>Watmuff</surname><given-names>B.</given-names></name><name><surname>Biag</surname><given-names>J. D.</given-names></name><name><surname>Thanos</surname><given-names>J. M.</given-names></name><name><surname>Whittredge</surname><given-names>P. B.</given-names></name></person-group>, <etal>et al</etal> (<year>2019</year>).
<article-title>Increased synapse elimination by microglia in schizophrenia
patient-derived models of synaptic pruning</article-title>. <source/>Nat
Neurosci, <volume>22</volume>,
<fpage>374</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0334-7</pub-id><pub-id pub-id-type="pmid">30718903</pub-id></mixed-citation>
</ref>
<ref id="bibr47-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>A.</given-names></name><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Kettenmann</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Cien Años de Microglía:
Milestones in a century of microglial research</article-title>.
<source/>Trends Neurosci, <volume>42</volume>,
<fpage>778</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2019.09.004</pub-id><pub-id pub-id-type="pmid">31635851</pub-id></mixed-citation>
</ref>
<ref id="bibr48-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. E. P.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Garbett</surname><given-names>K.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Maternal immune activation
alters fetal brain development through interleukin-6</article-title>.
<source/>J Neurosci, <volume>27</volume>,
<fpage>10695</fpage>–<lpage>10702</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2178-07.2007</pub-id><pub-id pub-id-type="pmid">17913903</pub-id></mixed-citation>
</ref>
<ref id="bibr49-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spalding</surname><given-names>K. L.</given-names></name><name><surname>Bergmann</surname><given-names>O.</given-names></name><name><surname>Alkass</surname><given-names>K.</given-names></name><name><surname>Bernard</surname><given-names>S.</given-names></name><name><surname>Salehpour</surname><given-names>M.</given-names></name><name><surname>Huttner</surname><given-names>H. B.</given-names></name></person-group>, <etal>et al</etal> (<year>2013</year>).
<article-title>Dynamics of hippocampal neurogenesis in adult
humans</article-title>. <source/>Cell, <volume>153</volume>,
<fpage>1219</fpage>–<lpage>1227</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.05.002</pub-id><pub-id pub-id-type="pmid">23746839</pub-id></mixed-citation>
</ref>
<ref id="bibr50-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spires-Jones</surname><given-names>T. L.</given-names></name><name><surname>Hyman</surname><given-names>B. T.</given-names></name></person-group> (<year>2014</year>). <article-title>The intersection of amyloid
beta and tau at synapses in Alzheimer’s disease</article-title>.
<source/>Neuron, <volume>82</volume>,
<fpage>756</fpage>–<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.05.004</pub-id><pub-id pub-id-type="pmid">24853936</pub-id></mixed-citation>
</ref>
<ref id="bibr51-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staszewski</surname><given-names>O.</given-names></name><name><surname>Hagemeyer</surname><given-names>N.</given-names></name></person-group> (<year>2019</year>). <article-title>Unique microglia expression
profile in developing white matter</article-title>. <source/>BMC Res
Notes, <volume>12</volume>, 367. <pub-id pub-id-type="doi">10.1186/s13104-019-4410-1</pub-id></mixed-citation>
</ref>
<ref id="bibr52-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St-Pierre</surname><given-names>M.-K.</given-names></name><name><surname>Bordeleau</surname><given-names>M.</given-names></name><name><surname>Tremblay</surname><given-names>M.-È.</given-names></name></person-group> (<year>2019</year>). <article-title>Visualizing dark
microglia</article-title>. <source/>Methods Mol Biol,
<volume>2034</volume>, <fpage>97</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-9658-2_8</pub-id><pub-id pub-id-type="pmid">31392680</pub-id></mixed-citation>
</ref>
<ref id="bibr53-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratoulias</surname><given-names>V.</given-names></name><name><surname>Venero</surname><given-names>J. L.</given-names></name><name><surname>Tremblay</surname><given-names>M.</given-names></name><name><surname>Joseph</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Microglial subtypes:
Diversity within the microglial community</article-title>. <source/>EMBO
J, <volume>38</volume>, e101997. <pub-id pub-id-type="doi">10.15252/embj.2019101997</pub-id></mixed-citation>
</ref>
<ref id="bibr54-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>T. L.</given-names></name><name><surname>Béchade</surname><given-names>C.</given-names></name><name><surname>D’Andrea</surname><given-names>I.</given-names></name><name><surname>St-Pierre</surname><given-names>M.-K.</given-names></name><name><surname>Henry</surname><given-names>M. S.</given-names></name><name><surname>Roumier</surname><given-names>A.</given-names></name></person-group>, <etal>et al</etal> (<year>2017</year>).
<article-title>Microglia gone rogue: Impacts on psychiatric disorders across
the lifespan</article-title>. <source/>Front Mol Neurosci,
<volume>10</volume>, <fpage>421</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00421</pub-id><pub-id pub-id-type="pmid">29354029</pub-id></mixed-citation>
</ref>
<ref id="bibr55-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M.-È.</given-names></name><name><surname>Lowery</surname><given-names>R. L.</given-names></name><name><surname>Majewska</surname><given-names>A. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Microglial interactions with
synapses are modulated by visual experience</article-title>. <source/>PLoS
Biol, <volume>8</volume>, <fpage>e1000527</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000527</pub-id><pub-id pub-id-type="pmid">21072242</pub-id></mixed-citation>
</ref>
<ref id="bibr56-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uranova</surname><given-names>N. A.</given-names></name><name><surname>Vikhreva</surname><given-names>O. V.</given-names></name><name><surname>Rakhmanova</surname><given-names>V. I.</given-names></name><name><surname>Orlovskaya</surname><given-names>D. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Ultrastructural pathology of
oligodendrocytes adjacent to microglia in prefrontal white matter in
schizophrenia</article-title>. <source/>NPJ Schizophr,
<volume>4</volume>, <fpage>26</fpage>
<pub-id pub-id-type="doi">10.1038/s41537-018-0068-2</pub-id><pub-id pub-id-type="pmid">30546020</pub-id></mixed-citation>
</ref>
<ref id="bibr57-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Cella</surname><given-names>M.</given-names></name><name><surname>Mallinson</surname><given-names>K.</given-names></name><name><surname>Ulrich</surname><given-names>J. D.</given-names></name><name><surname>Young</surname><given-names>K. L.</given-names></name><name><surname>Robinette</surname><given-names>M. L.</given-names></name></person-group>, <etal>et al</etal> (<year>2015</year>). <article-title>TREM2
lipid sensing sustains the microglial response in an Alzheimer’s disease
model</article-title>. <source/>Cell, <volume>160</volume>,
<fpage>1061</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.01.049</pub-id><pub-id pub-id-type="pmid">25728668</pub-id></mixed-citation>
</ref>
<ref id="bibr58-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinhard</surname><given-names>L.</given-names></name><name><surname>di Bartolomei</surname><given-names>G.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Machado</surname><given-names>P.</given-names></name><name><surname>Schieber</surname><given-names>N. L.</given-names></name><name><surname>Neniskyte</surname><given-names>U.</given-names></name></person-group>, <etal>et al</etal> (<year>2018</year>).
<article-title>Microglia remodel synapses by presynaptic trogocytosis and
spine head filopodia induction</article-title>. <source/>Nat Commun,
<volume>9</volume>, <fpage>1228</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-03566-5</pub-id><pub-id pub-id-type="pmid">29581545</pub-id></mixed-citation>
</ref>
<ref id="bibr59-1759091420925335">
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>S.</given-names></name><name><surname>Sillence</surname><given-names>D. J.</given-names></name></person-group> (<year>2019</year>). Niemann-Pick type C disease: Cellular
pathology and pharmacotherapy. <italic>J Neurochem</italic> Advance online
publication. <pub-id pub-id-type="doi">10.1111/jnc.14895</pub-id></mixed-citation>
</ref>
<ref id="bibr60-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wlodarczyk</surname><given-names>A.</given-names></name><name><surname>Holtman</surname><given-names>I. R.</given-names></name><name><surname>Krueger</surname><given-names>M.</given-names></name><name><surname>Yogev</surname><given-names>N.</given-names></name><name><surname>Bruttger</surname><given-names>J.</given-names></name><name><surname>Khorooshi</surname><given-names>R.</given-names></name></person-group>, <etal>et al</etal> (<year>2017</year>). <article-title>A novel
microglial subset plays a key role in myelinogenesis in developing
brain</article-title>. <source/>EMBO J, <volume>36</volume>,
<fpage>3292</fpage>–<lpage>3308</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201696056</pub-id><pub-id pub-id-type="pmid">28963396</pub-id></mixed-citation>
</ref>
<ref id="bibr61-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Ren</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Greenberg</surname><given-names>D. A.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name></person-group>, <etal>et al</etal> (<year>2017</year>).
<article-title>Age-related impairment of vascular structure and
functions</article-title>. <source/>Aging Dis, <volume>8</volume>,
<fpage>590</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2017.0430</pub-id><pub-id pub-id-type="pmid">28966804</pub-id></mixed-citation>
</ref>
<ref id="bibr62-1759091420925335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>Y.</given-names></name><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Sforazzini</surname><given-names>F.</given-names></name><name><surname>Weinhard</surname><given-names>L.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name></person-group>, <etal>et al</etal> (<year>2014</year>).
<article-title>Deficient neuron-microglia signaling results in impaired
functional brain connectivity and social behavior</article-title>.
<source/>Nat Neurosci, <volume>17</volume>,
<fpage>400</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3641</pub-id><pub-id pub-id-type="pmid">24487234</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>